blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2076515

EP2076515 - THIOPHENE PYRAZOLOPYRIMIDINE COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.05.2014
Database last updated on 03.09.2024
Most recent event   Tooltip24.07.2015Lapse of the patent in a contracting state
New state(s): BG, HU, LU		published on 26.08.2015  [2015/35]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[2013/29]
Former [2009/28]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis IN 46285 / US
Inventor(s)01 / CHEN, Zhaogen
10532 Titan Run
Carmel, Indiana 46032 / US
02 / HAMDOUCHI, Chafiq, Hamdouchi
14469 Twin Oaks Drive
Carmel, Indiana 46032 / US
03 / HEMBRE, Erik, James
1332 North New Jersey Street
Indianapolis, Indiana 46202 / US
04 / HIPSKIND, Philip, Arthur
4255 Cabin Court
New Palestine, Indiana 46163 / US
05 / JIA, Shaojuan
3865 Castle Rock Drive
Zionsville, Indiana 46077 / US
06 / TOTH, James, Lee
4642 South 625 West
Knightstown, Indiana 46148 / US
 [2009/28]
Representative(s)Bassinder, Emma Marie
Eli Lilly and Company Limited
8 Arlington Square West Downshire Way
Bracknell, Berkshire RG12 1PU / GB
[N/P]
Former [2013/29]Bassinder, Emma Marie
Eli Lilly and Company Limited European Patent Operations Lilly Research Centre, Erl Wood Manor Sunninghill Road
Windlesham, Surrey GU20 6PH / GB
Former [2009/28]Bassinder, Emma Marie
Eli Lilly and Company Limited European Patent Operations Lilly Research Centre, Erl Wood Manor Sunninghill Road
Windlesham, Surrey GU20 6PH / GB
Application number, filing date07814842.613.09.2007
[2009/28]
WO2007US78352
Priority number, dateUS20060826273P20.09.2006         Original published format: US 826273 P
[2009/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008036541
Date:27.03.2008
Language:EN
[2008/13]
Type: A1 Application with search report 
No.:EP2076515
Date:08.07.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 27.03.2008 takes the place of the publication of the European patent application.
[2009/28]
Type: B1 Patent specification 
No.:EP2076515
Date:17.07.2013
Language:EN
[2013/29]
Search report(s)International search report - published on:EP27.03.2008
ClassificationIPC:C07D487/04, A61K31/495, A61P25/24
[2009/28]
CPC:
C07D487/04 (EP,KR,US); A61K31/495 (KR); A61P1/04 (EP);
A61P15/00 (EP); A61P15/08 (EP); A61P15/10 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P25/04 (EP);
A61P25/06 (EP); A61P25/08 (EP); A61P25/20 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/32 (EP);
A61P25/36 (EP); A61P29/00 (EP); A61P3/04 (EP);
A61P35/00 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P5/24 (EP); A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/28]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:THIOPHENPYRAZOLOPYRIMIDINVERBINDUNGEN[2009/28]
English:THIOPHENE PYRAZOLOPYRIMIDINE COMPOUNDS[2009/28]
French:COMPOSÉS DE THIOPHÈNE PYRAZOLOPYRIMIDINE[2009/28]
Entry into regional phase20.04.2009National basic fee paid 
20.04.2009Designation fee(s) paid 
20.04.2009Examination fee paid 
Examination procedure02.04.2009Amendment by applicant (claims and/or description)
20.04.2009Examination requested  [2009/28]
05.08.2009Despatch of a communication from the examining division (Time limit: M04)
10.12.2009Reply to a communication from the examining division
15.02.2013Communication of intention to grant the patent
31.05.2013Fee for grant paid
31.05.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.08.2009
Opposition(s)22.04.2014No opposition filed within time limit [2014/26]
Fees paidRenewal fee
30.09.2009Renewal fee patent year 03
30.09.2010Renewal fee patent year 04
30.09.2011Renewal fee patent year 05
01.10.2012Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.09.2007
AT17.07.2013
BE17.07.2013
BG17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
LT17.07.2013
LV17.07.2013
MC17.07.2013
MT17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
TR17.07.2013
IE13.09.2013
LU13.09.2013
CH30.09.2013
LI30.09.2013
GR18.10.2013
IS17.11.2013
PT18.11.2013
[2015/34]
Former [2015/32]AT17.07.2013
BE17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
LT17.07.2013
LV17.07.2013
MC17.07.2013
MT17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
TR17.07.2013
IE13.09.2013
CH30.09.2013
LI30.09.2013
GR18.10.2013
IS17.11.2013
PT18.11.2013
Former [2014/34]AT17.07.2013
BE17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
LT17.07.2013
LV17.07.2013
MC17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
IE13.09.2013
CH30.09.2013
LI30.09.2013
GR18.10.2013
IS17.11.2013
PT18.11.2013
Former [2014/33]AT17.07.2013
BE17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
LT17.07.2013
LV17.07.2013
MC17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
IE13.09.2013
GR18.10.2013
IS17.11.2013
PT18.11.2013
Former [2014/23]AT17.07.2013
BE17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
LT17.07.2013
LV17.07.2013
MC17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
IS17.11.2013
PT18.11.2013
Former [2014/22]AT17.07.2013
BE17.07.2013
CY17.07.2013
DK17.07.2013
FI17.07.2013
LT17.07.2013
LV17.07.2013
MC17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
IS17.11.2013
PT18.11.2013
Former [2014/21]AT17.07.2013
BE17.07.2013
CY17.07.2013
DK17.07.2013
FI17.07.2013
LT17.07.2013
LV17.07.2013
MC17.07.2013
NL17.07.2013
PL17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
IS17.11.2013
PT18.11.2013
Former [2014/20]AT17.07.2013
BE17.07.2013
CY17.07.2013
FI17.07.2013
LT17.07.2013
LV17.07.2013
MC17.07.2013
NL17.07.2013
PL17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
IS17.11.2013
PT18.11.2013
Former [2014/18]AT17.07.2013
BE17.07.2013
CY17.07.2013
FI17.07.2013
LT17.07.2013
LV17.07.2013
NL17.07.2013
PL17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
IS17.11.2013
PT18.11.2013
Former [2014/14]AT17.07.2013
BE17.07.2013
FI17.07.2013
LT17.07.2013
LV17.07.2013
NL17.07.2013
PL17.07.2013
SE17.07.2013
SI17.07.2013
CY31.07.2013
GR18.10.2013
IS17.11.2013
PT18.11.2013
Former [2014/12]AT17.07.2013
BE17.07.2013
FI17.07.2013
LT17.07.2013
LV17.07.2013
PL17.07.2013
SE17.07.2013
SI17.07.2013
CY31.07.2013
GR18.10.2013
IS17.11.2013
PT18.11.2013
Former [2014/11]AT17.07.2013
BE17.07.2013
FI17.07.2013
LT17.07.2013
PL17.07.2013
SE17.07.2013
CY31.07.2013
IS17.11.2013
PT18.11.2013
Former [2014/10]AT17.07.2013
BE17.07.2013
LT17.07.2013
SE17.07.2013
CY31.07.2013
IS17.11.2013
PT18.11.2013
Former [2014/09]AT17.07.2013
BE17.07.2013
LT17.07.2013
SE17.07.2013
PT18.11.2013
Former [2014/08]LT17.07.2013
PT18.11.2013
Cited inInternational search[Y]WO2005063755  (SB PHARMCO INC [US], et al) [Y] 1-12 * page 1, line 11 - page 3, line 13 * * page 31 - page 32; examples 2-1--2-17 * * claim 1 *;
 [DY]WO9729109  (JANSSEN PHARMACEUTICA NV [BE], et al) [DY] 1-12 * page 1, line 5 - page 2, line 36 * * page 20 - page 23; table 4 * * claim 1 *;
 [A]WO0123388  (NEUROGEN CORP [US], et al) [A] 1-12 * page 1, line 18 - page 2, line 17 * * Table of examples; page 61 * * claim 1 *
 [Y]  - MAJO V.J. ET AL, "Facile Palladium-Catalyzed Synthesis of 3-Arylpyrazolo-[1,5a]pyrimidines", ADVANCED SYNTHESIS AND CATALYSIS, WILEY, WEINHEIM, DE, (200305), vol. 345, no. 5, ISSN 1615-4169, pages 620 - 624, XP002468036 [Y] 1-12 * page 1, paragraph 2 * * page 622; table 2; compound 6E *

DOI:   http://dx.doi.org/10.1002/adsc.200202191
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.